Abstract B243: A phase I dose-escalation study of MEK inhibitor MEK162 (ARRY-438162) in patients with advanced solid tumors.

出版年份 2012 全文链接

标题

作者

关键词

出版物

Volume 10, Issue Supplement 1, Pages B243-B243

出版商

American Association for Cancer Research (AACR)

发表日期

2012-06-27

DOI

10.1158/1535-7163.targ-11-b243

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now